References
- Al-Jameila N, Khana FA, Khana MF, Tabassuma HT. A brief overview of preeclampsia. J Clin Med Res 2014;6:1–7
- Uzan J, Carbonnel M, Piconne O, et al. Pre-eclampsia: pathophysiology, diagnosis, and management. Vascular Health Risk Manage 2011;7:467–74
- Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol 2010;5:173–92
- Karampas G, Eleftheriades M, Panoulis K, et al. Maternal serum levels of neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase-9 (MMP-9) and their complex MMP-9/NGAL in pregnancies with preeclampsia and those with a small for gestational age neonate: a longitudinal study. Prenatal Diagn 2014;34:726–33
- Kim SM, Park JS, Norwitz ER, et al. Circulating levels of NGAL correlate with the presence and severity of preeclampsia. Reprod Sci 2013;20:1083–89
- Giasson J, Li GH, Chen Y. Neutrophil gelatinase-associated lipocalin (NGAL) as a new biomarker for non-acute kidney injury (AKI) diseases. Inflamm Allergy Drug Targets 2011;10:272–82
- Schneider HG, Lam QT. Procalcitonin for the clinical laboratory: a review. Pathology 2007;39:383–90
- Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infect Dis 2013;13:426–35
- Meisner M. Update on procalcitonin measurements. Ann Lab Med 2014;34:263–73
- Kucukgoz Gulec U, Ozgunen FT, Guzel AB, et al. An analysis of C-reactive protein, procalcitonin, and D-dimer in pre-eclamptic patients. Am J Reprod Immunol 2012;68:331–7
- Montagnana M, Lippi G, Albiero A, et al. Procalcitonin values in preeclamptic women are related to severity of disease. Clin Chem Lab Med 2008;46:1050–1
- Can M, Sancar E, Harma M, et al. Inflammatory markers in preeclamptic patients. Clin Chem Lab Med 2011;49:1469–72
- ACOG commitee on obstetric practice. ACOG practice bulletin: diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Int J Gynecol Obstet 2002;77:67–75
- Van der Graaf AM, Wiegman MJ, Plösch T, et al. Endothelium-dependent relaxation and angiotensin II sensitivity in experimental preeclampsia. PLoS One 2013;8:e79884
- D’anna R, Baviera G, Giordano D, et al. Second trimester neutrophil gelatinase-associated lipocalin as a potential marker of preeclampsia. Acta Obstetricia et gynecologica 2008;87:1370–3
- D’anna R, Baviera G, Giordano D, et al. First trimester serum PAPP-A and NGAL in the prediction of late-onset preeclampsia. Prenat Diagn 2009;29:1066–8
- D’anna R, Baviera G, Giordano D, et al. Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. Acta Obstetricia et gynecologica 2010;89:275–8
- Youssef A, Righetti F, Morano D, et al. Uterine artery doppler and biochemical markers (PAPP-A, PIGF, sFlt-1, P-selectin, NGAL) at 11 + 0 to 13 + 6 weeks in the prediction of late (>34 weeks) preeclampsia. Prenat Diagn 2011;31:1141–6
- Patel ML, Sachan R, Gangwar R, et al. Correlation of serum neutrophil gelatinase-associated lipocalin with acute kidney injury in hypertensive disorders of pregnancy. Int J Nephrol Renovasc Dis 2013;6:181–6
- Scazzochio E, Munmany M, Garcia L, et al. Prognostic role of maternal neutrophil gelatinase-associated lipocalin in women with severe early onset preeclampsia. Fetal Diagn Ther 2014;35:127–32
- Odum L, Andersen AS, Hviid TV. Urinary neutrophil gelatinase-associated lipocalin (NGAL) excretion increases in normal pregnancy but not in preeclampsia. Clin Chem Lab Med 2014;52:221–5
- Gala-Bladzinska A, Kuzniewski M. Performance of neutrophil gelatinase-associated lipocalin in clinical settings. Przegl Lek 2013;70:400–3
- Xiao J, Niu J, Ye X, et al. Combined biomarkers evaluation for diagnosing kidney injury in preeclampsia. Hypertens Pregn 2013;32:439–49
- Elneihoum AM, Falke P, Hedblad B, et al. Leukocyte activation in atherosclerosis: correlation with risk factors. Atherosclerosis 1997;131:79–84
- Sachan R, Patel Ml, Gaurav A, Angwar R. Serum neutrophil gelatinase–associated lipocalin: predictor of pre-eclampsia, eclampsia and ıts correlation with severity of disease. Int J Med Med Sci 2013;46:1170–8. ISSN:2051-5731
- Petla LT, Chikkala R, Ratnakar KS, et al. Biomarkers fort he management of preeclampsia in pregnant women. Indian J Med Res 2013;138:60–7